#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypertriglyceridaemia Brain abscess Epstein-Barr virus infection Narcolepsy Myxofibrosarcoma Eosinophilic oesophagitis Oesophageal squamous cell carcinoma stage II Oesophageal achalasia Primary adrenal insufficiency Hyperinsulinism Bulbospinal muscular atrophy congenital Myxoid liposarcoma Homocystinuria Neonatal alloimmune thrombocytopenia Immunodeficiency common variable More trials…

    Learn about Rare Diseases

    Arterial tortuosity syndrome – Trials in Disease Alveolar rhabdomyosarcoma – Treatment Marginal zone lymphoma refractory – Diagnostics Activated PI3 kinase delta syndrome – Trials in Disease Haemolytic uraemic syndrome – Trials in Disease Gastrointestinal stromal tumour – Trials in Disease Haemophilia B with anti factor IX – Diagnostics Acquired haemophilia – Treatment Synovial sarcoma – Treatment Progressive multifocal leukoencephalopathy – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VG801-2 Acou085 Tucatinib Clofazimine Nystatin MB-001 Tezepelumab ICOTROKINRA Mk-4830 Filgotinib Gsk3965193B VENT-03 Irbesartan Abc-35B-116 Ag13909 Valproate Semisodium Iph6501 ZUNIBERGENE ROCPARVOVEC Platelet Concentrate VINBLASTINE More therapies…

    Learn about Your Condition

    Papilloma viral infection Hyperphagia Encephalopathy neonatal Carcinoid tumour pulmonary Lupus nephritis Clinically isolated syndrome Urticaria Spinal osteoarthritis Labour induction Necrotising myositis Bladder cancer stage II Cluster headache Alveolar proteinosis Weaning failure Postprandial hypoglycaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Górnośląskie Centrum Zdrowia Dziecka

Górnośląskie Centrum Zdrowia Dziecka

Medyków 16, Katowice, 40-758, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness of Sirolimus and Trametinib for Treating Diffuse Intrinsic Pontine Glioma in Children Aged 3-18 Years

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Brain stem glioma
    Investigated Drugs:
    • Sirolimus
    • Trametinib
    Poland

  • Study on Doxorubicin, Fluorouracil, and Oxaliplatin for Children and Adolescents with Primary Malignant Liver Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatoblastoma
    Investigated Drugs:
    • Sorafenib Tosilate
    • Sodium Thiosulfate
    • Irinotecan Hydrochloride
    Poland

  • Study on the Safety and Effectiveness of Sirolimus for Treating High-Grade Glioma in Children

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Sirolimus
    Poland

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!